Skincare Ingredient Science and Derm Studies — 2026-09-12
The global skincare industry is pivoting toward "Blue Peptides," a new class of anti-aging ingredients positioning themselves as successors to retinol and PDRN, highlighted by recent launches in South Korea. Meanwhile, the first consumer products containing the newly FDA-approved sunscreen filter Bemotrizinol (BEMT) are hitting U.S. shelves, marking the end of a 27-year regulatory freeze on new UV filters.
Skincare Ingredient Science and Derm Studies — 2026-09-12
Top developments
Korean Brand TOUN28 Unveils "Blue Peptide" as Next-Gen Anti-Aging Active
On September 11, 2026, Korean beauty brand TOUN28 hosted its "2026 TOUN28 2.0 UNPACK" event in Seoul, introducing "Blue Peptide" as a novel ingredient designed to stimulate the skin’s inherent activity rather than just supplementing it. This launch follows market trends where consumers are moving beyond traditional ingredients like retinol and PDRN, seeking mechanisms that "wake up" skin health from within. The move signals a shift in the K-beauty sector toward ingredient innovation focused on endogenous activation
First Bemotrizinol (BEMT) Sunscreen Products Debut in U.S. Market
Following the FDA's June 2026 approval of Bemotrizinol as the first new UV filter in decades, the first commercial products are now available in the United States as of early September 2026. Drug Topics reports that dsm-firmenich’s Parsol Shield and Ultra Violette have launched SPF products utilizing this filter, which allows for higher concentrations (up to 6%) and broader UVA/UVB protection compared to older filters like avobenzone. This release addresses a long-standing gap where U.S. consumers lacked access to filters widely used in Europe and Asia for over 20 years
Clinical Review Highlights Peptide Efficacy for Skin Aging
A new review published in Mathrubhumi English on September 9, 2026, analyzes the efficacy of peptide serums amidst the growing trend of "peptide therapy." While acknowledging that peptides are ubiquitous in marketing, the article synthesizes current research indicating their potential in enhancing collagen production and improving skin elasticity, though it notes that clinical evidence varies by peptide type and concentration. This comes as search data indicates a surge in interest for peptides globally, often positioned as gentler alternatives to retinoids
Dermatology Times Reviews September Journal Digests
On September 9, 2026, Dermatology Times released its weekly journal digest, summarizing key findings from recent dermatological studies. While not exclusively focused on topical ingredients, the digest highlights adverse events associated with cutaneous procedures and phototherapy outcomes, providing context for how professional treatments intersect with at-home ingredient regimens like retinoids and exfoliants. These syntheses are critical for clinicians advising patients on the safety profiles of combining procedural treatments with active skincare ingredients
Local view
South Korea: Local media is heavily focusing on the "Blue Peptide" trend. BioTimes reported on September 9 that the anti-aging mechanism is shifting from simple ingredient infusion to inducing skin activity, with "Blue Peptide" emerging as a key successor to PDRN and Retinol. The narrative emphasizes a scientific basis for "awakening" skin power, aligning with the TOUN28 launch
Japan: Japanese beauty media continues to emphasize the combination of Retinaldehyde and Peptides. Recent reviews from platforms like LIPS and Maquia highlight products such as VT Cosmetics' "Retinal Peptide Serum," noting positive user feedback on pore care and texture improvement over two-week trials. Dermatologist-led content remains high, explaining the synergistic effects of these ingredients
Context & numbers
- Regulatory Milestone: Bemotrizinol was added to the FDA OTC sunscreen monograph in June 2026, effective August 9, 2026, permitting concentrations up to 6% for adults and children aged 6 months and older
- Market Shift: In South Korea, consumer purchasing decisions are increasingly driven by specific ingredients ("ingredient-centric consumption") rather than just brand or claimed efficacy, with PDRN, Retinol, and now Peptides leading search trends
- Launch Timing: The first BEMT-containing products reached U.S. shelves in early September 2026, approximately one month after the effective date of the FDA final order
On the radar
- BEMT Formulation Expansion: Watch for additional brands launching BEMT-containing sunscreens in Q4 2026 as supply chains for the raw material stabilize following the August effective date.
- "Blue Peptide" Global Adoption: Monitor if other major Korean or international brands adopt the "Blue Peptide" terminology or similar "activity-inducing" peptide technologies in upcoming product launches.
- Fall/Sun Protection Season: As autumn approaches in the Northern Hemisphere, interest in barrier-repairing ingredients (ceramides, peptides) typically rises, potentially shifting focus away from aggressive actives like high-concentration retinoids.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
